SciVision Biotech Inc.
SciVision Biotech Inc., headquartered in Taiwan (TW), is a leading player in the biotechnology industry, specialising in innovative solutions for the healthcare sector. Founded in 2005, the company has made significant strides in developing advanced diagnostic tools and therapeutic products, positioning itself as a trusted name in the field. With a focus on molecular diagnostics and biopharmaceuticals, SciVision Biotech offers unique products that leverage cutting-edge technology to enhance patient care. Their commitment to quality and innovation has earned them recognition in both domestic and international markets, solidifying their reputation as a pioneer in biotechnology. As they continue to expand their operational reach, SciVision Biotech remains dedicated to advancing healthcare through scientific excellence and innovative solutions.
DitchCarbon Score
How does SciVision Biotech Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
SciVision Biotech Inc.'s score of 17 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
SciVision Biotech Inc.'s reported carbon emissions
In 2023, SciVision Biotech Inc., headquartered in Taiwan (TW), reported total greenhouse gas emissions of approximately 130,899.3 kg CO2e, comprising 23,212.5 kg CO2e from Scope 1 and 107,686.8 kg CO2e from Scope 2. This marks an increase in emissions compared to 2022, where the company recorded about 90,378.2 kg CO2e (21,952.9 kg CO2e from Scope 1 and 68,425.3 kg CO2e from Scope 2). Despite these figures, there are currently no disclosed reduction targets or climate pledges from SciVision Biotech Inc. This absence of specific commitments highlights a potential area for improvement in their climate strategy. The company has reported greenhouse gas emission intensity metrics, indicating a focus on emissions relative to revenue, but lacks comprehensive data on Scope 3 emissions or any formal reduction initiatives. As the industry increasingly prioritises sustainability, SciVision Biotech Inc. may benefit from establishing clear climate commitments and reduction targets to align with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 21,952.9 | 00,000.0 |
| Scope 2 | 68,425.3 | 000,000.0 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
SciVision Biotech Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
